Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.

Rinne, U K

Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial. [electronic resource] - Journal of neurology Dec 1975 - 1-9 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article

0340-5354

10.1007/BF00312459 doi


Adult
Aged
Aromatic Amino Acid Decarboxylase Inhibitors
Benserazide--administration & dosage
Blood Pressure--drug effects
Clinical Trials as Topic
Drug Therapy, Combination
Female
Humans
Hydrazines--administration & dosage
Levodopa--administration & dosage
Male
Middle Aged
Movement Disorders--chemically induced
Nausea--chemically induced
Parkinson Disease--drug therapy
Vomiting--chemically induced